Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1015
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2012  |  Volume : 19  |  Issue : 1  |  Page : 36-39

Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos


1 Department of Haematology and Blood Transfusion, Lagos State University Teaching Hospital, P.M.B 21105 Ikeja, Lagos, Nigeria
2 Department of Haematology and Immunology, Obafemi Awolowo University, Ile- Ife, Nigeria

Correspondence Address:
T M Balogun
P O Box 10315, G PO, Bank Anthony Way, Ikeja, Lagos
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Aims and objectives: This study was undertaken (i) to determine the seroprevalence of antibodies to Hepatitis C virus (anti -HCV) among blood donors (ii) to document the incidence of known risk factors for HCV infection among blood donors. Patients and Methods: This is a cross sectional prospective study among apparently normal blood donors. Subjects were recruited from three different hospitals in Lagos metropolis. All recruited donors were evaluated for HCV infection- associated risk factors by questionnaire interviews. Sera samples from recruited donors were tested for anti-HCV using third generation Murex (Murex Biotech, South Africa) and fourth generation Dialab Enzyme Linked Immunosorbent Assay (ELISA) kits (Dialab. Austria). Results: A total of three hundred and thirty four blood donors were screened, of which seven (2.1 %) were positive for anti-HCV. The blood donors comprised 15 (4.5 %) females and 319 (95.5 %) males. There was an association between anti-HCV positivity and history of multiple sex partners and previous sexually transmitted infections (X2-15.9; p<0.05) Majority of blood donors were family replacement 317 (94.9 %) with anti-HCV prevalence of 2.2 % (7/317) while 5.1 % (17/334) were voluntary non remunerated with anti-HCV prevalence of 0% (p>0.05) Conclusion: Prevalence of anti-HCV among blood donors in Lagos (2.1%) is low as in most previous reports from Nigeria and some other parts of Africa


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed662    
    Printed8    
    Emailed0    
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal